Stereotaxis, Inc. (STXS)

↓ Download CSV

CIK 0001289340 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Stereotaxis, Inc. reported revenue of $32.38M, up 20.3% from the prior year. The company ran a net loss, with a net margin of -66.8% and a gross margin of 52.7%. It held $52.25M in total assets against $33.53M in total liabilities.

Key ratios (FY2025)

52.7%
Gross margin
-68.3%
Operating margin
-66.8%
Net margin
-160.5%
Return on equity
+20.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$32.38M$26.92M$26.77M$28.15M$35.02M$26.63M$28.90M$29.35M
Cost of Revenue$15.31M$12.32M$11.91M$9.68M$11.79M$7.66M$6.14M$5.72M$10.75M$7.53M
Gross Profit$17.07M$14.59M$14.86M$18.47M$23.23M$18.97M$22.77M$23.63M$20.39M$24.63M
Operating Income-$22.11M-$24.74M-$21.84M-$18.78M-$12.89M-$6.71M-$4.83M-$2.46M-$5.92M-$6.43M
Net Income-$21.64M-$24.05M-$20.71M-$18.29M-$10.72M-$6.65M-$4.59M$116.8K-$5.89M-$5.29M
EPS (Diluted)$-0.25$-0.30$-0.27$-0.26$-0.16$-0.11$-0.10$-0.03$-0.32$-0.54
Total Assets$52.25M$46.72M$41.91M$53.41M$60.98M$55.46M$43.58M$18.51M$10.67M$20.97M
Total Liabilities$33.53M$35.29M$19.99M$21.48M$21.56M$15.23M$15.06M$11.24M$31.27M$36.50M
Shareholders' Equity$13.48M$6.08M$16.34M$26.35M$33.84M$34.62M$22.77M$1.31M-$26.57M-$21.49M
Cash & Equivalents$13.42M$12.22M$19.82M$8.59M$38.74M$43.94M$30.18M$10.80M$3.69M$8.50M
Operating Cash Flow-$13.69M-$8.50M-$9.14M-$8.41M-$2.95M-$3.51M-$4.62M-$2.55M-$4.67M
Capital Expenditures$93.0K$34.0K$366.0K$2.38M$1.40M$70.9K$29.5K$265.5K$81.6K$410.2K
Shares Outstanding90.96M85.18M80.70M76.06M75.56M72.75M63.05M52.08M22.61M21.81M